Multicentre retrospective analysis of second allogeneic HSCT outcomes for haematologic malignancies in Korea

被引：0
|
作者：
Kim, K. H. [1 ]
Jung, C. W. [2 ]
Jang, J. H. [2 ]
Kim, K. [2 ]
Ahn, H. K. [2 ]
Won, J. H. [1 ]
Hong, D. S. [3 ]
Moon, J. H. [4 ]
Sohn, S. K. [4 ]
Kim, Y. K. [5 ]
Yang, D. H. [5 ]
Lee, J. J. [5 ]
Kim, H. J. [5 ]
Kim, J. S. [6 ]
Min, Y. H. [6 ]
Kim, D. Y. [7 ]
Lee, J. H. [7 ]
Lee, J. H. [7 ]
Lee, K. H. [7 ]
Kim, I. [8 ]
Yoon, S. S. [8 ]
Park, S. [8 ]
Lee, S. M. [9 ]
Joo, Y. D. [9 ]
Jun, H. J. [10 ]
Kim, D. H. [2 ]
机构：
[1] Soonchunhyang Univ Hosp, Seoul, South Korea
[2] Samsung Med Ctr, Seoul, South Korea
[3] Soonchunhyang Univ Hosp, Puchon, South Korea
[4] Kyungpook Natl Univ Hosp, Taegu, South Korea
[5] Chonnam Natl Univ, Sch Med, Kwangju, South Korea
[6] Yonsei Univ, Severance Hosp, Seoul 120749, South Korea
[7] Asan Med Ctr, Seoul, South Korea
[8] Seoul Natl Univ, Coll Med, Seoul, South Korea
[9] Busan Paik Hosp, Pusan, South Korea
[10] Konyang Univ Hosp, Taejon, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [1] Cytoreductive therapy with clofarabin followed by HLA-haplo-identical BMT/HSCT in advanced/refractory haematologic malignancies and in relapse after allogeneic HSCT
    Hausmann, A.
    Hill, W.
    Ledderose, G.
    Fritsch, S.
    Engel, N.
    Rothmayer, M.
    Huettinger, S.
    Reibke, R.
    Otten, S.
    Humann, M.
    Teepe, C.
    Braess, J.
    Kolb, H. -J.
    Tischer, J.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S357 - S357
  • [2] Impact of route and adequacy of nutritional intake on outcomes of allogeneic haematopoietic cell transplantation for haematologic malignancies
    Beckerson, Julie
    Szydlo, Richard M.
    Hickson, Mary
    Mactier, Catriona E.
    Innes, Andrew J.
    Gabriel, Ian H.
    Palanicawandar, Renuka
    Kanfer, Edward J.
    Macdonald, Donald H.
    Milojkovic, Dragana
    Rahemtulla, Amin
    Chaidos, Aristeidis
    Karadimitris, Anastasios
    Olavarria, Eduardo
    Apperley, Jane F.
    Pavlu, Jiri
    CLINICAL NUTRITION, 2019, 38 (02) : 738 - 744
  • [3] SECOND ALLOGENEIC STEM CELL TRANSPLANTATION IN HEMATOLOGICAL MALIGNANCIES; A SINGLE CENTER RETROSPECTIVE ANALYSIS
    Schade, H.
    Humpe, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (01) : 409 - 409
  • [4] Outcomes of Second Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Children
    Schechter, Tal
    Avila, Laura
    Dupuis, L. Lee
    Pollock-BarZiv, Stacey
    Gassas, Adam
    Finkelstein, Yaron
    Armstrong, Christine
    Doyle, John J.
    BLOOD, 2008, 112 (11) : 1119 - 1119
  • [5] Second allogeneic stem cell transplantation as salvage of relapsed haematologic malignancies after stem cell transplantation
    Tan, T.
    Wu, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S258 - S259
  • [6] Second allogeneic hematopoietic stem cell transplantation (HSCT) in patients with refractory hematological malignancies.
    Hosing, C
    De Lima, M
    Saliba, RM
    Shahjahan, M
    Couriel, D
    Andersson, B
    Giralt, S
    Champlin, RE
    BLOOD, 2002, 100 (11) : 430A - 430A
  • [7] Second allogeneic HSCT in patients with acute leukaemia relapsed after a first allogeneic transplantation: a retrospective GITMO study
    Dominietto, A.
    Bacigalupo, A.
    Bruno, B.
    Zecca, M.
    Falda, M.
    Di Bartolomeo, P.
    Arcese, W.
    Bosi, A.
    Fagioli, F.
    Iannitto, E.
    Favre, C.
    Rambaldi, A.
    Pession, A.
    Bandini, G.
    Ciceri, F.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S16 - S17
  • [8] Second Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Relapse of Hematological Malignancies after First Allo-HSCT
    Kato, Koji
    Miyamoto, Toshihiro
    Yonemoto, Koji
    Uchida, Naoyuki
    Ogawa, Hiroyasu
    Fukuda, Takahiro
    Takahashi, Satoshi
    Ohashi, Kazuteru
    Eto, Tetsuya
    Nagamura-Inoue, Tokiko
    Sakamaki, Hisashi
    Morishima, Yasuo
    Suzuki, Ritsuro
    Atsuta, Yoshiko
    Akashi, Koichi
    BLOOD, 2014, 124 (21)
  • [9] GVHD PREVENTION IN ALLOGENEIC HSCT FOR LYMPHOMAS: A SINGLE CENTER RETROSPECTIVE ANALYSIS
    Barbato, F.
    Defrancesco, I.
    Olivieri, J.
    Dicataldo, M.
    Zazzeroni, L.
    Rizzi, S.
    Tassi, C.
    Casadei, B.
    Cavo, M.
    Zinzani, P. L.
    Arpinati, M.
    Bonifazi, F.
    HAEMATOLOGICA, 2021, 106 (10) : 177 - 178
  • [10] Comparison of Outcomes of Donor Lymphocyte Infusions With or Without Lenalidomide in Patients with Hematological Malignancies Post Allogeneic HSCT
    Punatar, Sachin
    Murugaiyan, Vinodhini
    Kumbhalwar, Komal
    Gokarn, Anant
    Chichra, Akanksha
    Mirgh, Sumeet
    Nayak, Lingaraj
    Bonda, Avinash
    Jindal, Nishant
    Shirure, Vijay
    Bagal, Bhausaheb
    Mathew, Libin
    Kannan, Sadhana
    Saikia, Tapan
    Khattry, Navin
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2023, 39 (01) : 40 - 49
12345